News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,626 Results
Type
Article (39100)
Company Profile (280)
Press Release (646246)
Section
Business (203905)
Career Advice (1990)
Deals (35373)
Drug Delivery (85)
Drug Development (80800)
Employer Resources (169)
FDA (16088)
Job Trends (14807)
News (344595)
Policy (32453)
Tag
Academia (2530)
Alliances (49092)
Alzheimer's disease (1228)
Approvals (16020)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11535)
Biotechnology (201)
Breast cancer (119)
Cancer (1075)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (231)
Clinical research (64229)
Collaboration (383)
Compensation (197)
COVID-19 (2530)
C-suite (94)
Data (1117)
Diabetes (152)
Diagnostics (6146)
Earnings (84817)
Employer resources (147)
Events (109450)
Executive appointments (307)
FDA (16618)
Funding (346)
Gene therapy (176)
GLP-1 (575)
Government (4329)
Healthcare (18671)
Infectious disease (2614)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16296)
Job creations (3626)
Job search strategy (1418)
Layoffs (413)
Legal (7859)
Lung cancer (170)
Manufacturing (177)
Medical device (13175)
Medtech (13180)
Mergers & acquisitions (19148)
Metabolic disorders (398)
Neuroscience (1503)
NextGen Class of 2024 (6505)
Non-profit (4464)
Northern California (1474)
Obesity (228)
Opinion (180)
Patents (101)
People (56273)
Phase I (19945)
Phase II (28289)
Phase III (21095)
Pipeline (454)
Postmarket research (2553)
Preclinical (8487)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5893)
Regulatory (21527)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1297)
Startups (3565)
United States (13375)
Vaccines (548)
Weight loss (166)
Date
Today (130)
Last 7 days (825)
Last 30 days (3748)
Last 365 days (35590)
2024 (32585)
2023 (40089)
2022 (51181)
2021 (55718)
2020 (54100)
2019 (46549)
2018 (35028)
2017 (32143)
2016 (31497)
2015 (37560)
2014 (31322)
2013 (26349)
2012 (28577)
2011 (29266)
2010 (27331)
Location
Africa (714)
Arizona (192)
Asia (37136)
Australia (6058)
California (3308)
Canada (1282)
China (246)
Colorado (143)
Connecticut (150)
Europe (79514)
Florida (455)
Georgia (116)
Illinois (338)
Indiana (195)
Kansas (96)
Maryland (573)
Massachusetts (2586)
Michigan (157)
Minnesota (271)
New Jersey (947)
New York (949)
North Carolina (696)
Northern California (1474)
Ohio (138)
Pennsylvania (838)
South America (1092)
Southern California (1297)
Texas (458)
Utah (90)
Washington State (357)
685,626 Results for "illumina inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Illumina completes the divestiture of GRAIL
Illumina, Inc. announced the successful completion of the spin-off of GRAIL. This milestone follows the company’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company.
June 24, 2024
·
6 min read
Press Releases
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
November 21, 2024
·
4 min read
Business
Illumina Lays Out Growth Roadmap After Grail Divestment
In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and improved data analysis for customers.
August 14, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Illumina To Webcast Upcoming May 2024 Investor Conference
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 15, 2024
·
1 min read
Business
Illumina appoints Everett Cunningham Chief Commercial Officer
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10.
June 3, 2024
·
2 min read
Biotech Beach
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc., a global leader in DNA sequencing and array-based technologies, published its fifth annual Corporate Social Responsibility Report.
May 28, 2024
·
4 min read
Biotech Beach
Illumina To Webcast Upcoming Investor Conference - May 03, 2024
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 3, 2024
·
1 min read
Biotech Beach
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of DRAGEN™ v4.3, the latest version of its DRAGEN™ software, part of the Illumina Connected Software portfolio, for analysis of next-generation sequencing data.
June 11, 2024
·
5 min read
Biotech Beach
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
Illumina, Inc. announced that its Board of Directors has approved the spin-off of GRAIL.
June 3, 2024
·
6 min read
Business
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
May 2, 2024
·
24 min read
1 of 68,563
Next
